Project Description

CURE MEMBER DIRECTORY
454-sequencing-225px_w

Torigen Pharmaceuticals, Inc.

Cell & Genome Science Building R1855 CB129
400 Farmington Ave.
Farmington, CT 06032

Phone: 860-519-9956
Website: www.vetivax.com

Contact:
Ashley Kalinauskas, CEO – A.Kalinauskas@vetivax.com

General Information
Torigen Pharmaceuticals, Inc. is focused on providing veterinary cancer care solutions for companion animals. Our novel, personalized immunotherapy uses the animals’ existing tumor cells to fight cancer. When combined with an innovative bulking agent, MIM™ (matrix immune modulator), an overall reduction in tumor size and inhibition of metastasis has been observed throughout multiple peer-reviewed publications. This is the basis and foundation for Torigen’s personalized veterinary cancer treatment, VetiVax.

Research Activities
Personalized cancer immunotherapies for the veterinary market. Have completed extensive safety trials and are continuing to gather efficacy data.

> Return to CURE Member Directory